Evoke Pharma, Inc. Gains 37.16%

Wed, Dec 07, 2022 at 07:00 PM
Evoke Pharma, Inc. Gains 37.16%

Evoke Pharma, Inc. (EVOK:NASDAQ) shot up at $2.03, representing a gain of 37.2%. On Wed, Dec 07, 2022, EVOK:NASDAQ touched a New 2-Week High of $2.03. The stock appeared on our News Catalysts scanner on Wed, Dec 07, 2022 at 10:09 AM in the 'PRIVATE PLACEMENT' category. From Wed, Nov 23, 2022, the stock recorded 66.67% Up Days and 60.00% Green Days

About Evoke Pharma, Inc. (EVOK:NASDAQ)

Evoke Pharma Inc is a specialty pharmaceutical company which focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. It is engaged in developing an investigational metoclopramide nasal spray called Gimoti.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.